|
26 Feb 2026 |
Balkrishna Industries
|
Consensus Share Price Target
|
2434.10 |
2384.67 |
- |
-2.03 |
hold
|
|
|
|
|
29 Jan 2026
|
Balkrishna Industries
|
Motilal Oswal
|
2434.10
|
2229.00
|
2364.20
(2.96%)
|
Target met |
Neutral
|
|
|
Balkrishna Industries’ (BIL) 3Q earnings at INR3.8b were above our estimate of INR2.8b, primarily due to MTM gains of INR360m and higher other income.
|
|
29 Jan 2026
|
Balkrishna Industries
|
ICICI Direct
|
2434.10
|
2500.00
|
2364.20
(2.96%)
|
Target met |
Hold
|
|
|
Near-term demand weakness persists at its core OHT business: BKT operates in a niche off highway tyre (OHT) segment which finds application in agriculture and mining/industrial purposes. Currently it has ~5-6% market share in the global OHT space and has been long aspiring to take it to ~8-10% in years to come. BKT however faces persistent nearterm demand weakness in its key markets of the US and Europe due to global macro uncertainties. Recent US trade policies have increased tariffs on Indian firms from 10% to 50% since August 2025, which sharply increases cost pressures and risks a significant reduction in US boundshipment, representing ~15% of its revenue. Consequently, company...
|
|
21 Nov 2025
|
Balkrishna Industries
|
Deven Choksey
|
2434.10
|
2370.00
|
2299.70
(5.84%)
|
Target met |
Hold
|
|
|
While near-term demand remains uneven across international markets, management commentary suggests gradual stabilization supported by normalization in freight, moderating raw material costs, and improved replacement demand.
|
|
02 Nov 2025
|
Balkrishna Industries
|
Motilal Oswal
|
2434.10
|
2257.00
|
2279.80
(6.77%)
|
Target met |
Neutral
|
|
|
Balkrishna Industries’ (BIL) 2Q earnings at INR2.7b were below our estimate of INR3.7b due to an adverse mix, the impact of US tariffs, and weak demand.
|
|
23 Sep 2025
|
Balkrishna Industries
|
Geojit BNP Paribas
|
2434.10
|
2678.00
|
2496.50
(-2.50%)
|
Target met |
Hold
|
|
|
BKT's sales volume was impacted by tariff-related disruptions, leading to a volatile ordering cycle in April. Ongoing trade tensions and geopolitical challenges in key export markets have dampened customer sentiment. However, the company expects the ordering cycle to normalise with a permanent tariff structure. BKT has been gaining brand acceptance in the Indian market and aims to enhance it further by launching into the PCR and CV segments. With expansions in the OHT segment...
|
|
22 May 2025
|
Balkrishna Industries
|
Ventura
|
2434.10
|
2417.00
|
2649.60
(-8.13%)
|
Target met |
Sell
|
|
|
Black & White
|
|
02 Apr 2025
|
Balkrishna Industries
|
Geojit BNP Paribas
|
2434.10
|
2770.00
|
2567.10
(-5.18%)
|
Target met |
Hold
|
|
|
|
|
27 Jan 2025
|
Balkrishna Industries
|
Motilal Oswal
|
2434.10
|
2630.00
|
2564.65
(-5.09%)
|
Target met |
Neutral
|
|
|
Balkrishna Industries (BIL) delivered an operationally in-line performance in 3QFY25, with Fx gains driving an Adj. PAT beat at INR4.4b (up 43% YoY, vs. est. INR3.8b).
|
|
27 Oct 2024
|
Balkrishna Industries
|
Motilal Oswal
|
2434.10
|
2890.00
|
2907.55
(-16.28%)
|
Target met |
Neutral
|
|
|
Balkrishna Industries (BIL)’s 2QFY25 was operationally better than expected with EBITDA of INR6.2b (+13% YoY, est. INR5.9b), led by better ASP and lower promotional expenses.
|
|
14 Aug 2024
|
Balkrishna Industries
|
Keynote Capitals Ltd
|
2434.10
|
3024.00
|
2781.45
(-12.49%)
|
Target met |
Neutral
|
|
|
Quarterly Update Q1FY25
|
|
12 Aug 2024
|
Balkrishna Industries
|
Sharekhan
|
2434.10
|
3195.00
|
2844.65
(-14.43%)
|
|
Buy
|
|
|
A 4.7% beat in topline resulted in in-line EBITDA, though PAT was 14.3% above estimates on higherthan-expected other income.
|
|
21 May 2024
|
Balkrishna Industries
|
Keynote Capitals Ltd
|
2434.10
|
2995.00
|
3052.70
(-20.26%)
|
Target met |
Neutral
|
|
|
Quarterly Update Q4FY24
|
|
21 May 2024
|
Balkrishna Industries
|
ICICI Direct
|
2434.10
|
3250.00
|
3052.70
(-20.26%)
|
Target met |
Hold
|
|
|
|
|
18 May 2024
|
Balkrishna Industries
|
Sharekhan
|
2434.10
|
3195.00
|
2797.75
(-13.00%)
|
Target met |
Buy
|
|
|
Strong earnings beat on robust volume growth (+12.8% q-o-q), healthy realisations (+3.9% q-o-q), and sharp gross margin expansion (+160bps q-o-q). Revenue and EBITDA exceeded estimates by 16.2% and 18.2%, respectively.
|
|
29 Jan 2024
|
Balkrishna Industries
|
Keynote Capitals Ltd
|
2434.10
|
2376.00
|
2508.70
(-2.97%)
|
Target met |
Sell
|
|
|
Quarterly Update Q3FY24
|
|
24 Oct 2023
|
Balkrishna Industries
|
ICICI Securities Limited
|
2434.10
|
2709.00
|
2566.90
(-5.17%)
|
Target met |
Accumulate
|
|
|
Balkrishna Industries (BIL)’s Q2FY24 EBITDAM, at 24.4%, was up 170bps QoQ driven by a combination of lower raw material basket (RMB) cost, better product mix and favourable hedge rate. Post-inventory destocking at the dealer level in the last few quarters, inventory is now at normalised levels of 2-3 months, from highs of ~4 months.
|
|
23 Oct 2023
|
Balkrishna Industries
|
Keynote Capitals Ltd
|
2434.10
|
2708.00
|
2566.90
(-5.17%)
|
Target met |
Neutral
|
|
|
Quarterly Update Q2FY24
|
|
23 Oct 2023
|
Balkrishna Industries
|
Sharekhan
|
2434.10
|
2720.00
|
2592.85
(-6.12%)
|
Target met |
Hold
|
|
|
|
|
23 Oct 2023
|
Balkrishna Industries
|
Motilal Oswal
|
2434.10
|
2500.00
|
2566.90
(-5.17%)
|
Target met |
Neutral
|
|
|
|
|
19 Oct 2023
|
Balkrishna Industries
|
ICICI Securities Limited
|
2434.10
|
2709.00
|
2576.10
(-5.51%)
|
Target met |
Accumulate
|
|
|
Indian OHT exports in Aug’23 improved 4%/1% MoM/YoY and now is back in line with average monthly exports in CY23. Agri segment exports increased 6% MoM to ~USD 90mn as against OTR segment’s exports being at their highest in CY23 at USD 52mn, flat MoM. With export base reducing substantially from Aug’23, YoY, industry has shifted from a declining trajectory to a growing one.
|